Algiers, DZWatch – Algeria has been selected by the World Health Organization (WHO) to host the first-ever African Ministerial Conference on Local Pharmaceutical Production and Health Technologies. This decision underscores Algeria’s continental leadership in the pharmaceutical industry, according to President Abdelmadjid Tebboune.
The announcement, made on Thursday, solidifies Algeria’s position as a key player in the development and advancement of pharmaceutical manufacturing across Africa. The conference, scheduled for November 27, 2025, will bring together ministers, industry experts, and stakeholders from across the continent to discuss strategies for boosting local production of essential medicines and health technologies.
President Tebboune emphasized the significance of this event for Algeria, highlighting the country’s commitment to strengthening its pharmaceutical sector and contributing to the overall health security of the African continent. He stated that Algeria has made significant strides in developing its own pharmaceutical manufacturing capabilities and is well-positioned to share its expertise with other African nations.
“This is a testament to Algeria’s dedication to building a robust and self-sufficient pharmaceutical industry,” a government spokesperson told DZWatch. “We are honored to host this important conference and look forward to working with our African partners to advance the local production of medicines and health technologies.”
The conference is expected to focus on key areas such as technology transfer, regulatory harmonization, financing mechanisms, and skills development. The ultimate goal is to reduce Africa’s reliance on imported pharmaceuticals and ensure access to affordable, high-quality medicines for all Africans.
The selection of Algeria as the host country reflects the country’s growing influence in the region and its commitment to promoting intra-African cooperation in the health sector. The government has pledged to provide all necessary support to ensure the success of the conference and to contribute to its long-term impact on the African pharmaceutical landscape.
